Position in RYTM
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$206,448,951
-$66,116,741 QoQ
Shares Held
2,373,795
-6.8% QoQ
Ownership
3.46%
of shares outstanding
% of Portfolio
4.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PERCEPTIVE ADVISORS LLC holds $4,570,707,559 across 67 Biotechnology names. RYTM ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $655,974,329 | |
| 2 | CELC |
Celcuity Inc.
|
3,127,200 | $356,938,608 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,531,421 | $350,281,925 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
8,285,461 | $229,507,269 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
5,258,903 | $208,883,627 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
This page
|
2,373,795 | $206,448,951 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
3,783,225 | $190,825,869 | |
| 8 | NUVL |
Nuvalent, Inc.
|
1,580,505 | $161,922,737 |
All Filings in RYTM
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $206,448,951 | 2,373,795 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $272,565,692 | 2,546,391 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $42,079,099,340 | 416,666,000 | Principal | Sole | 2025-11-14 | |
| 2025-09-30 | $246,311,479 | 2,438,969 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $152,812,313 | 2,418,299 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $134,991,131 | 2,548,445 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $206,032,878 | 3,680,473 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $186,519,611 | 3,560,214 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $141,516,533 | 3,446,579 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $141,627,528 | 3,268,579 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $99,024,436 | 2,154,110 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $8,730,481 | 380,828 | Shares | Sole | 2023-11-14 | |
| 2020-03-31 | $2,600,473 | 170,859 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||